As of 31 July 2026, 2 Indian mutual funds hold Hikal Limited (Healthcare), led by ICICI Prudential Pharma Healthcare and Diagnostics Fund at 1.18% of its net assets, per the AMCs' SEBI-mandated monthly disclosures.
As of 31 July 2026, 2 Indian mutual fund schemes disclose a holding in Hikal Limited (Healthcare). The table below lists every fund holding this stock along with its weight as a percentage of the fund's net assets (% to NAV), sorted from the highest conviction position downward.
Across the 2 funds holding Hikal Limited, the average position size is 0.88% of net assets. The highest-conviction holder is ICICI Prudential Pharma Healthcare and Diagnostics Fund (Thematic), at 1.18%. Thematic funds account for 1 of the 2 holders, with the rest spread across 1 other category. Over the last month, 0 funds initiated a new position and 0 funds exited, with the largest weight change at ICICI Prudential Pharma Healthcare and Diagnostics Fund (-0.16pp to 1.18%).
How funds changed their Hikal Limited position between their two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Fund | Weight | Change |
|---|---|---|
| ICICI Prudential Pharma Healthcare and Diagnostics Fund | 1.34% → 1.18% | ▼ -0.16 |
| # | Fund | AMC | Category | % to NAV |
|---|---|---|---|---|
| 1 | ICICI Prudential Pharma Healthcare and Diagnostics Fund | ICICI Prudential Mutual Fund | Thematic | 1.18% |
| 2 | TATA SMALL CAP FUND | Tata Mutual Fund | Equity | 0.58% |
Want to interpret these weights? Read How to Read a Mutual Fund's Monthly Portfolio Disclosure, or look up terms like % to NAV and conviction in the glossary.
Source: SEBI-mandated monthly portfolio disclosures by Indian AMCs. Percentages are of each fund's net assets on its latest disclosure date. For information only, not investment advice.